Literature DB >> 33431938

Association of GZMB polymorphisms and susceptibility to non-segmental vitiligo in a Korean population.

Ki-Heon Jeong1, Su Kang Kim2, Jong-Kil Seo3, Min Kyung Shin3, Mu-Hyoung Lee3.   

Abstract

Non-segmental vitiligo (NSV) is the most common type of vitiligo, which is characterized by chronic and progressive loss of melanocytes. Genetic factors have been shown to play a key role in NSV in association and family studies. Granzyme B is a serine protease found in the cytoplasmic granules of cytotoxic T lymphocytes and natural killer cells that play an important role in inducing apoptotic changes of target cells. Several recent studies have provided evidence that polymorphism in the GZMB gene might be associated with autoimmune disease. A total of 249 NSV patients and 455 healthy controls were recruited to determine whether single nucleotide polymorphisms (SNPs) [rs2236337 (3' untranslated region, UTR), rs2236338 (Tyr247His), rs11539752 (Pro94Ala), rs10909625 (Lys80Lys), rs8192917 (Arg55Gln), and rs7144366 (5' near gene)] in GZMB gene contribute to the risk of developing NSV. Genotyping was performed using a single 192.24 Dynamic Array IFC. Data were analyzed using EP1 SNP Genotyping Analysis software to obtain genotype calls. Among the six SNPs tested, five SNPs (rs2236337, rs2236338, rs11539752, rs10909625, and rs8192917) showed significant association with NSV susceptibility. Among them, rs2236338, rs11539752, rs10909625, and rs8192917 remained a statistically significant association following multiple correction test. The five SNPs were located within a block of linkage disequilibrium. Haplotypes T-A-G-T-T and C-G-C-C-C consisting of rs2236337, rs2236338, rs11539752, rs10909625, and rs8192917 demonstrated significant association with NSV. Our results suggest that GZMB polymorphisms are associated with the development of NSV.

Entities:  

Year:  2021        PMID: 33431938      PMCID: PMC7801456          DOI: 10.1038/s41598-020-79705-0

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  47 in total

1.  Epidemiology of vitiligo and associated autoimmune diseases in Caucasian probands and their families.

Authors:  Asem Alkhateeb; Pamela R Fain; Anthony Thody; Dorothy C Bennett; Richard A Spritz
Journal:  Pigment Cell Res       Date:  2003-06

Review 2.  Genetics of Vitiligo.

Authors:  Richard A Spritz; Genevieve H L Andersen
Journal:  Dermatol Clin       Date:  2017-04       Impact factor: 3.478

3.  An effector phenotype of CD8+ T cells at the junction epithelium during clinical quiescence of herpes simplex virus 2 infection.

Authors:  Tao Peng; Jia Zhu; Khamsone Phasouk; David M Koelle; Anna Wald; Lawrence Corey
Journal:  J Virol       Date:  2012-07-18       Impact factor: 5.103

Review 4.  A Practical Approach to the Diagnosis and Treatment of Vitiligo in Children.

Authors:  Khaled Ezzedine; Nanette Silverberg
Journal:  Pediatrics       Date:  2016-06-21       Impact factor: 7.124

5.  QPY/RAH haplotypes of the GZMB gene are associated with natural killer cell cytotoxicity.

Authors:  Wataru Oboshi; Toru Watanabe; Keisuke Hayashi; Takehiro Nakamura; Nobuyasu Yukimasa
Journal:  Immunogenetics       Date:  2017-06-26       Impact factor: 2.846

6.  Global activation of CD8+ cytotoxic T lymphocytes correlates with an impairment in regulatory T cells in patients with generalized vitiligo.

Authors:  Yang Lili; Wei Yi; Yang Ji; Sun Yue; Shi Weimin; Li Ming
Journal:  PLoS One       Date:  2012-05-23       Impact factor: 3.240

Review 7.  Six decades of vitiligo genetics: genome-wide studies provide insights into autoimmune pathogenesis.

Authors:  Richard A Spritz
Journal:  J Invest Dermatol       Date:  2011-10-13       Impact factor: 8.551

8.  Genome-wide association studies of autoimmune vitiligo identify 23 new risk loci and highlight key pathways and regulatory variants.

Authors:  Ying Jin; Genevieve Andersen; Daniel Yorgov; Tracey M Ferrara; Songtao Ben; Kelly M Brownson; Paulene J Holland; Stanca A Birlea; Janet Siebert; Anke Hartmann; Anne Lienert; Nanja van Geel; Jo Lambert; Rosalie M Luiten; Albert Wolkerstorfer; J P Wietze van der Veen; Dorothy C Bennett; Alain Taïeb; Khaled Ezzedine; E Helen Kemp; David J Gawkrodger; Anthony P Weetman; Sulev Kõks; Ele Prans; Külli Kingo; Maire Karelson; Margaret R Wallace; Wayne T McCormack; Andreas Overbeck; Silvia Moretti; Roberta Colucci; Mauro Picardo; Nanette B Silverberg; Mats Olsson; Yan Valle; Igor Korobko; Markus Böhm; Henry W Lim; Iltefat Hamzavi; Li Zhou; Qing-Sheng Mi; Pamela R Fain; Stephanie A Santorico; Richard A Spritz
Journal:  Nat Genet       Date:  2016-10-10       Impact factor: 38.330

9.  Risk of generalized vitiligo is associated with the common 55R-94A-247H variant haplotype of GZMB (encoding granzyme B).

Authors:  Tracey M Ferrara; Ying Jin; Katherine Gowan; Pamela R Fain; Richard A Spritz
Journal:  J Invest Dermatol       Date:  2013-01-15       Impact factor: 8.551

10.  High frequency of skin-homing melanocyte-specific cytotoxic T lymphocytes in autoimmune vitiligo.

Authors:  G S Ogg; P Rod Dunbar; P Romero; J L Chen; V Cerundolo
Journal:  J Exp Med       Date:  1998-09-21       Impact factor: 14.307

View more
  2 in total

1.  Whole Genome Sequencing Provides New Insights Into the Genetic Diversity and Coat Color of Asiatic Wild Ass and Its Hybrids.

Authors:  Hong Dong; Zheng Dong; Fuwen Wang; Gang Wang; Xiaoyu Luo; Chuzhao Lei; Jingbo Chen
Journal:  Front Genet       Date:  2022-05-12       Impact factor: 4.772

2.  Skin Interstitial Fluid and Plasma Multiplex Cytokine Analysis Reveals IFN-γ Signatures and Granzyme B as Useful Biomarker for Activity, Severity and Prognosis Assessment in Vitiligo.

Authors:  Chau Yee Ng; Yen-Chuan Chiu; Yu-Pei Chan; Yu-Jr Lin; Pei-Han Chung; Wen-Hung Chung; Cheng-Lung Ku
Journal:  Front Immunol       Date:  2022-04-07       Impact factor: 8.786

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.